deflazacort

This page shows the latest deflazacort news and features for those working in and with pharma, biotech and healthcare.

Pfizer abandons antibody for Duchenne

to treat the symptoms of DMD – called Emflaza (deflazacort) – last year.

Mallinckrodt doses first patient in muscular dystrophy trial

but was rejected in the US, and novel steroid Emflaza (deflazacort) from Marathon Pharma.
FDA reviewer unimpressed with PTC’s Translarna

saying its commercial operations were already in gear following the FDA’s approval of Emflaza (deflazacort) for DMD earlier this year.
Connecting the dots

Not just any drug mind you - a decades-old corticosterioid called Emflaza (deflazacort) that is available elsewhere for about $1, 500 per year.
Marathon pauses Emflaza launch amid pricing furore

In a nutshell, they want Marathon to justify its claim that the cost of developing Emflaza for DMD warrants that price tag, given that deflazacort a is "widely available abroad for
FDA approves first steroid for Duchenne muscular dystrophy

Emflaza (deflazacort) is the first corticosteroid to be approved by the FDA to treat DMD, said the US agency in a statement. ... Complicating the picture is that deflazacort has been available outside the US for decades and patients have been able to

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Deal Watch March 2017

230. Marathon. PTC Therapeutics. Product acquisition. Emflaza (deflazacort), marketed for Duchenne Muscular Dystrophy.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

No results were found

Add my company

Fox&cat is a new kind of fully-integrated communications agency – one that delivers genuinely inspirational campaigns and programmes with equal...

Archetypes: Rethinking go-to-market expectations to drive commercial success: In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge: Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications: Want to learn how to close the distance between a person’s current health and their healthiest possible self?...

Email:
Password: